Drreddys Laboratories | RDY - Stock


Drreddys Laboratories reported INR76.53B in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
ANI Pharmaceuticals USD 143.47M 401K Mar/2026
Aurora Cannabis CAD 175.08M 55.48M Mar/2026
Bayer EUR 12.34B 3M Dec/2025
Canopy Growth CAD 110.51M 4.96M Mar/2026
Cipla INR 61.6B 5.18B Sep/2025
Corcept Therapeutics USD 12.89M 22K Mar/2026
Drreddys Laboratories INR 76.53B 2.48B Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Hikma Pharmaceutical USD 1.08B 96M Jun/2025
Lonza CHF 1.68B 163M Dec/2025
Novartis USD 6.29B 17M Mar/2026
Pacira USD 150.37M 2.49M Mar/2026
Phibro Animal Health USD 539.7M 22.35M Mar/2026
Prestige Brands USD 159.13M 4.46M Mar/2026
Richter Gedeon HUF 205.75B 9.76B Jun/2024
Sun Pharmaceuticals INR 102.43B 3.08B Mar/2025
Supernus Pharmaceuticals USD 110.77M 1.71M Mar/2026
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025